274 related articles for article (PubMed ID: 10335865)
1. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro.
Panther LA; Coombs RW; Aung SA; dela Rosa C; Gretch D; Corey L
J Med Virol; 1999 Jun; 58(2):165-73. PubMed ID: 10335865
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
[TBL] [Abstract][Full Text] [Related]
3. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
[TBL] [Abstract][Full Text] [Related]
4. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
Perno CF; Newcomb FM; Davis DA; Aquaro S; Humphrey RW; Caliò R; Yarchoan R
J Infect Dis; 1998 Aug; 178(2):413-22. PubMed ID: 9697721
[TBL] [Abstract][Full Text] [Related]
5. A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitro.
Moussazadeh M; Hua J; Sidhu MK; Zhao XX; Fitzgibbon JE; Liao MJ; Rashidbaigi A
Antiviral Res; 1999 Jul; 42(3):177-87. PubMed ID: 10443530
[TBL] [Abstract][Full Text] [Related]
6. [Detection of unintegrated forms of proviral DNA in HIV infections].
Gashnikova NM; Pyasek A; Iagudin BI; Mamaeva OA; Pokrovskiĭ AG
Vestn Ross Akad Med Nauk; 1998; (3):13-7. PubMed ID: 9608270
[TBL] [Abstract][Full Text] [Related]
7. An HIV-1 protease screening assay using a non-infectious proviral clone.
Heldsinger AA; Antonucci T
J Virol Methods; 1994 Oct; 49(3):247-55. PubMed ID: 7868643
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.
Nagy K; Young M; Baboonian C; Merson J; Whittle P; Oroszlan S
J Virol; 1994 Feb; 68(2):757-65. PubMed ID: 8289379
[TBL] [Abstract][Full Text] [Related]
9. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors.
Surdo M; Cortese MF; Orlandi C; Di Santo F; Aquaro S; Magnani M; Perno CF; Casabianca A; Ceccherini-Silberstein F
Antiviral Res; 2018 Dec; 160():165-174. PubMed ID: 30420339
[TBL] [Abstract][Full Text] [Related]
10. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
11. Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART.
Nicastri E; Tommasi C; Abbate I; Bonora S; Tempestilli M; Bellagamba R; Viscione M; Rozera G; Gallo AL; Ivanovic J; Amendola A; Pucillo L; Di Perri G; Capobianchi MR; Narciso P
Antivir Ther; 2011; 16(6):797-803. PubMed ID: 21900711
[TBL] [Abstract][Full Text] [Related]
12. Abortive infection in HeLaCD4 cells by a primary HIV type 1 isolate: implications for differential host cell tropism.
Smyth RJ; Yi Y; Kim FM; Collman RG
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):759-69. PubMed ID: 9171220
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 expression by HIV-2.
Rappaport J; Arya SK; Richardson MW; Baier-Bitterlich G; Klotman PE
J Mol Med (Berl); 1995 Dec; 73(12):583-9. PubMed ID: 8825754
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
Kim JH; McLinden RJ; Mosca JD; Burke DS; Boswell RN; Birx DL; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):329-42. PubMed ID: 8673541
[TBL] [Abstract][Full Text] [Related]
15. Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.
Merrill DP; Manion DJ; Chou TC; Hirsch MS
J Infect Dis; 1997 Jul; 176(1):265-8. PubMed ID: 9207379
[TBL] [Abstract][Full Text] [Related]
16. Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.
Jacobsen H; Ahlborn-Laake L; Gugel R; Mous J
J Virol; 1992 Aug; 66(8):5087-91. PubMed ID: 1378515
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
Witvrouw M; Pannecouque C; Desmyter J; De Clercq E; Andries K
Antiviral Res; 2000 Jun; 46(3):215-21. PubMed ID: 10867159
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs.
Mayers DL
Am J Med; 1997 May; 102(5B):70-5. PubMed ID: 9845501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
